Pancreatic Cancer Research

ResearcherBeckman Research InstituteActive in the last 2 years

Anna M Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8487-823X; OpenAlex author ID A5034028155; NIH RePORTER profile ID 1930027. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
2
Labs led
2
Collaborators
8
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 grant · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 grant

Papers 3

  1. Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody. Last author DOI 10.2967/jnumed.117.207332↗
  2. A mutated anti-CA19-9 scFv-Fc for positron emission tomography of human pancreatic cancer xenografts. Co-author DOI 10.1007/s11307-014-0733-4↗
  3. An engineered anti-CA19-9 cys-diabody for positron emission tomography imaging of pancreatic cancer and targeting of polymerized liposomal nanoparticles. Co-author DOI 10.1016/j.jss.2013.05.095↗

Grants 2

  1. Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer R01CA266665↗
  2. Multifunctional immunoPET tracers for pancreatic and prostate cancer R01CA174294↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kirstin Anja Zettlitz · 1 shared grant, 2026 · strength 1.26
  2. Robert E Reiter · 1 shared paper, 1 shared grant, 2018–2020 · strength 0.57
  3. Timothy R. Donahue · 1 shared paper, 2018 · strength 0.09
  4. Kirstin A. Zettlitz · 1 shared paper, 2018 · strength 0.09
  5. Mark D. Girgis MD · 2 shared papers, 2013–2014 · strength 0.09
  6. James Steven Tomlinson · 2 shared papers, 2013–2014 · strength 0.09
  7. Matthew M. Rochefort · 2 shared papers, 2013–2014 · strength 0.09
  8. Jacob S. Ankeny · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.